This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Agency for Science, Technology and Research, National University Hospital (Singapore) Pte. Ltd., National University of Singapore. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025-2026
Title: Aditi Qamra: Innovator in Cancer Research
Introduction
Aditi Qamra is a prominent inventor based in Singapore, known for her significant contributions to cancer research. She has developed innovative methods that enhance the understanding and treatment of cancer, particularly gastric adenocarcinoma. Her work is pivotal in the field of epigenomics, providing insights that could lead to improved cancer diagnostics and therapies.
Latest Patents
Aditi holds a patent titled "Epigenomic profiling reveals the somatic promoter landscape of primary gastric adenocarcinoma." This invention relates to a method for determining the presence or absence of at least one promoter in a cancerous biological sample compared to a non-cancerous biological sample. Additionally, it encompasses methods for determining cancer prognosis, modulating cancer-associated promoter activity, and enhancing the immune response to cancer. This patent represents a significant advancement in cancer detection and treatment.
Career Highlights
Aditi Qamra is affiliated with the Agency for Science, Technology and Research, where she applies her expertise in cancer research. Her innovative approaches have garnered attention in the scientific community, contributing to the advancement of cancer therapies and diagnostics.
Collaborations
Aditi collaborates with esteemed colleagues such as Patrick Tan and Manjie Xing, further enriching her research endeavors. These collaborations enhance the impact of her work and foster a multidisciplinary approach to cancer research.
Conclusion
Aditi Qamra's contributions to cancer research through her innovative patent and collaborative efforts highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also holds the potential to improve patient outcomes in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile